BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:56 PM
 | 
Aug 30, 2007
 |  BC Extra  |  Top Story

EC approves EPO biosimilar

The European Commission granted the first marketing approval for a biosimilar version of epoetin alfa. The EC approved three applications for the same product,...

Read the full 101 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >